Back

Comparison of clinical outcomes in diabetic and non-diabetic patients undergoing coronary bifurcation stenting

30 August 2024 (09:00 - 09:30)
Organised by: Logo
Congress Presentation Part of: The association of diabetes and renal disease with poor percutaneous coronary intervention outcomes Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Assistant Professor Subin Lim

Ewha Womans University, Seoul (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
Influence of acute kidney injury and chronic kidney disease on 3-year clinical outcomes in patients with AMI treated by contemporary PCI and optimal medical therapy; insights from J-MINUET study
Professor Y. Ozaki (Aichi, JP)
Abstract Slides Video
Presentation thumbnail
A simplified bedside model for acute kidney injury prediction after percutaneous coronary intervention
Assistant Professor D. Balanescu (Rochester, US)
Abstract Slides Video
Presentation thumbnail
The risk factors for in-stent restenosis following drug-eluting stent implantation in end-stage renal disease patients receiving renal replacement therapy
Mr T. Issarawattana (Nakhon Si Thammarat, TH)
Abstract Slides Video
Presentation thumbnail
Long-term outcome of diabetic patients after unprotected left main percutaneous coronary interventions
Doctor O. Nemeth (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Comparative clinical outcomes of amphilimus-eluting stents in diabetic versus non-diabetic patients
Assistant Professor J. Kim (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
The association of diabetes and renal disease with poor percutaneous coronary intervention outcomes

The Event

Event poster

ESC Congress 2024

30 August 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Comparative clinical outcomes of amphilimus-eluting stents in diabetic versus non-diabetic patients
thumbnail
Congress Presentation
Three-year outcome after coronary stenting in all-comer patients: Impact of diabetes and peripheral arterial disease
thumbnail
Congress Presentation
Are newer-generation stents as good as CABG in type 2 diabetes?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources